The Technical Analyst
Select Language :
Enlighta Inc. [NLTA.V]

Exchange: TSX Sector: Healthcare Industry: Health Information Services

Enlighta Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Enlighta Inc. is listed at the  Exchange

0.00% $0.0650

America/New_York / 9 des 2022 @ 15:13


FUNDAMENTALS
MarketCap: 1.110 mill
EPS: -0.295
P/E: -0.220
Earnings Date: N/A
SharesOutstanding: 17.08 mill
Avg Daily Volume: 0.0032 mill
RATING 2023-02-09
B-
Neutral
RATINGS
Rating CashFlow: Strong Buy
Return On Equity: Neutral
Return On Asset: Strong Sell
DE: Sell
P/E: Sell
Price To Book: Neutral
QUARTER GROWTHS
3/214/211/222/223/224/22
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debtn/an/an/an/an/an/a
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.220 | sector: PE -0.175
PE RATIO: COMPANY / INDUSTRY
0x
Company: PE -0.220 | industry: PE -9.13
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0 - 0

( +/- 0.00%)
ATR Model: 14 days
Profile picture for
            Enlighta Inc.

NLTA.V

Enlighta Inc., a development stage company, operates as a healthcare and medical digital, green, and clean technology company. The company was formerly known as HooXi Network Inc. and changed its name to Enlighta Inc. in July 2019. Enlighta Inc. was incorporated in 2010 and is based in Road Town, the British Virgin Islands.

Last 10 Buy Signals

Date Signal @
PTENMay 3 - 15:24$10.64
PENDLEUSDMay 3 - 15:235.02
USDCUSDMay 3 - 15:23$0.999
COOMay 3 - 15:23$90.92
GNSUSDMay 3 - 15:203.43
WSTETHUSDMay 3 - 15:213 572.35
RTYUSDMay 3 - 15:122 042.20
BTGUSDMay 3 - 15:20$33.76
TSCOMay 3 - 15:19$270.33
TXRHMay 3 - 15:18$164.01

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.